Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Breast Cancer Radiation Guidelines Called Positive Step
The new medical consensus statement on accelerated partial breast irradiation is an important step toward defining patient selection criteria and highlights the importance of targeting radiation, said two of the nation"s leading APBI physicians.

Cimzia(R), The Only PEGylated Anti-TNF, Recommended For Approval In The EU For Rheumatoid Arthritis
UCB announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending that the European Commission grants a marketing authorisation for Cimzia® (certolizumab pegol), in combination with methotrexate (MTX), for the treatment of moderate to severe active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs (DMARDs) including MTX, has been inadequate. In these patients, Cimzia® can be given as monotherapy in case of intolerance to MTX or when continued treatment with MTX is inappropriate. Cimzia® has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function, when given in combination with MTX.
News of the day
Surprising Findings May Yield Insights Into Human Developmental Disorders: Researchers Discover Evolutionary Event Underlying The Origin Of Dachshunds
A single evolutionary event appears to explain the short, curved legs that characterize all of today"s dachshunds, corgis, basset hounds and at least 16 other breeds of dogs, a team led by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, report. In addition to what it reveals about short-legged dogs, the unexpected discovery provides new clues about how physical differences may arise within species and suggests new approaches to understanding a form of human dwarfism.
Nutrition

Numbers Of People With MS Higher Than Previously Estimated

New research released by the MS Society has for the first time revealed an accurate estimate of the number of people living with a diagnosis of multiple sclerosis (MS) in the UK. The results show that there is likely to be around 100,000 people with MS in the UK - a 20 per cent increase on previous estimates. The new study of GP records - funded by the MS Society - was carried out by the London School of Hygiene and Tropical Medicine and updates previous estimates of 85,000. The revised figure has major implications for health and social services and the study is a precursor to a pilot MS Register, which will provide much more information on exactly how MS affects individuals. MS Society Chief Executive, Simon Gillespie, said: "For the first time, we have the right information on the numbers of people with MS. Based on this information, we will seek to work with local health and social services across the UK to improve services for people with MS. "This is just the beginning. As part of its leadership of a European initiative, the MS Society will now fund a pilot MS Register, which will provide much more information on how MS affects individuals. "If this pilot proves successful, we hope the governments in all four nations of the UK will support the introduction of a complete register." The study was brought about following work carried out by MS Society members in Hampshire, who found that in their local area, the previous estimated prevelance rate was inaccurate. Knowing how many people have MS is important so that health and social services can provide the right types of care and support. In many areas of the country people do not currently have access to all the nursing care, drugs and treatment regime that they so desperately need. Read the full Strength in Numbers briefing document - MS prevalence study briefing June 2009.pdf (201 kb) Download the Strength in Numbers campaign leaflet - Strength in Numbers.pdf MS Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009